Motilal Oswal's research report on Amara Raja
Amara Raja’s (ARENM) 1QFY25 financials were weak, with EBITDA margin contracting ~90bp QoQ to 13.7% (est. 14.8%). The margin contraction was due to a shift in the product mix, with traded goods rising to 23% of revenue (vs. ~12% in 4QFY24), along with some increase in RM costs. On a positive note, the quarter saw healthy volume growth in most segments. We cut FY25E/FY26E EPS by 10%/6% to factor in the increase in commodity prices. While market seems to be upbeat about ARENM’s lithium ion foray, we remain circumspect of the returns from the business. The stock at ~28x/24x FY25/26E EPS appears fairly valued. We, hence, maintain Neutral rating with a revised TP of INR1,390 (based on 20x June-26E EPS).
Outlook
While the market is optimistic about ARENM’s li-ion initiative, we are cautious about its potential returns. We believe the stock trading at around 28x/24x FY25/26E EPS appears fairly valued. Therefore, we maintain a Neutral rating with a revised target price of INR 1390, based on 20x June-26E EPS.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
